News

Published on 4 May 2023 on Zacks via Yahoo Finance

DaVita (DVA) to Report Q1 Earnings: What's in the Offing?


Article preview image

DaVita Inc. DVA is scheduled to release first-quarter 2023 results on May 8, after the closing bell.

In the last reported quarter, the company’s earnings of $1.11 per share surpassed the Zacks Consensus Estimate by 26.1%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on two occasions and lagged the same in the other two, delivering an earnings surprise of 2.5%, on average.

Let’s see how things have shaped up prior to this announcement.

NYSE.DVA price evolution
NASDAQ.APTX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.65% By Investing.com

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.65%

Investing.com 5 May 2023

Ultragenyx (RARE) Q1 Earnings and Revenues Miss Estimates

Ultragenyx Pharmaceutical Inc. RARE incurred a loss of $2.33 per share in first-quarter 2023, wid...

Zacks via Yahoo Finance 5 May 2023

McKesson (MCK) to Report Q4 Earnings: Is a Beat in Store?

McKesson Corporation MCK is scheduled to report fiscal fourth-quarter 2023 results on May 8, afte...

Zacks via Yahoo Finance 5 May 2023

Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day...

Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day...

Investing.com 5 May 2023

Deciphera (DCPH) Q1 Earnings Match Estimates, Sales Miss

Deciphera Pharmaceuticals, Inc. DCPH reported a first-quarter 2023 loss of 60 cents per share, wh...

Zacks via Yahoo Finance 4 May 2023

DaVita (DVA) to Report Q1 Earnings: What's in the Offing?

DaVita Inc. DVA is scheduled to release first-quarter 2023 results on May 8, after the closing be...

Zacks via Yahoo Finance 4 May 2023

Aeterna (AEZS) Falls 5% on US Sales Halt of Growth Hormone Drug

Aeterna Zentaris AEZS stock dropped 4.8% on Wednesday after the company announced that sales of M...

Zacks via Yahoo Finance 6 Apr 2023

Here's Why You Should Add Acadia (ACAD) Stock to Your Portfolio

Acadia Pharmaceuticals Inc. ACAD is a San Diego, CA-based biopharmaceutical company, focused on d...

Zacks via Yahoo Finance 6 Apr 2023

Phathom (PHAT) Up 8% on Erosive Esophagitis Drug's CRL Update

Phathom Pharmaceuticals PHAT stock jumped 8.42% on Tuesday after the company announced a positive...

Zacks via Yahoo Finance 5 Apr 2023

Seagen's (SGEN) Padcev & Keytruda Combo Gets FDA Accelerated Nod

Seagen Inc. SGEN and partner, Astellas Pharma, announced that the FDA has granted accelerated app...

Zacks via Yahoo Finance 4 Apr 2023